IP Library Granted Patent US 7,928,212
Granted Patent B2
US 7,928,212 · App. 12/817,089 · Granted Apr 19, 2011

Gene upregulated in cancers of the prostate

Assignee: Agensys, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,928,212
App. No.
12/817,089
Granted
Apr 19, 2011
Kind
B2
Abstract

The present invention relates to a novel protein designated 20P2H8 which shares homology with several heterogeneous nuclear ribonucleoproteins (hnRNPs). A full length approximately 3600 bp 20P2H8 cDNA (SEQ ID NO: 1, encoding a 517 amino acid open reading frame (SEQ ID NO: 2), is provided herein.

Claims (19)

1. An isolated nucleotide sequence comprising an uninterrupted sequence of nucleotides that encodes the polypeptide of SEQ ID NO:2.

2. The isolated nucleotide sequence of claim 1 , wherein the sequence comprises the nucleotide sequence of SEQ ID NO:1.

3. The isolated nucleotide sequence of claim 1 , wherein the sequence comprises nucleotides 451 to 2001 of SEQ ID NO:1.

4. An isolated recombinant expression vector comprising a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:2.

5. The recombinant expression vector of claim 4 , wherein the nucleotide sequence comprises the nucleotide sequence of SEQ ID NO:1.

6. The recombinant expression vector of claim 4 , wherein the nucleotide sequence comprises nucleotides 451 to 2001 of SEQ ID NO:1.

7. The recombinant vector of claim 4 , wherein the vector further comprises one or more regulatory sequences.

8. The recombinant vector of claim 4 , wherein the vector further comprises a stop codon associated with the nucleotide sequence.

9. The recombinant expression vector of claim 4 , wherein the vector is a viral vector.

10. The recombinant expression vector of claim 7 , wherein the viral vector is a vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, or Sindbis virus.

11. An isolated host cell comprising a recombinant comprising a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:2.

12. The host cell of claim 11 , wherein the nucleotide sequence comprises the nucleotide sequence of SEQ ID NO:1.

13. The host cell of claim 11 , wherein the nucleotide sequence comprises nucleotides 451 to 2001 of SEQ ID NO:1.

14. A method of producing a polypeptide, comprising:

providing a host cell, wherein the host cell comprises an expression vector and wherein the expression vector comprises a nucleotide sequence encoding the polypeptide of SEQ ID NO:2; and

culturing the host cell under conditions to produce the polypeptide.

15. The method of claim 14 , wherein the host cell is prokaryotic or eukaryotic.

16. The method of claim 14 , wherein the nucleotide sequence encoding the polypeptide comprises the nucleotide sequence of SEQ ID NO: 1.

17. The method of claim 14 , further comprising purifying the polypeptide produced.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2010
From: AFAR, DANIEL E.H.; RAITANO, ARTHUR B.; HUBERT, RENE S.; MITCHELL, STEVE CHAPPELL; JAKOBOVITS, AYA
To: AGENSYS, INC.
Reel/Frame 024554/0704 →
CHANGE OF NAME Recorded Jun 17, 2010
From: UROGENESYS, INC.
To: AGENSYS, INC.
Reel/Frame 024554/0745 →
Continuity (5)
Continuation 12170208 · Jul 9, 2008
Continuation 10959697 · Oct 5, 2004
Continuation 09697206 · Oct 26, 2000
Provisional Application 60162364 · Oct 28, 1999
Related Publication 20100255535A1 · Oct 7, 2010